A complete application in a minute
Tailored resume and cover letter, ready to send.
Iovance Biotherapeutics, Inc. is seeking a senior field leader to serve as Business Development Director, Sales for a large U.S. territory.
Reporting to the Vice President, US Sales, this role leads relationships with oncology accounts, authorized treatment centers, health systems, and healthcare leaders to drive commercial growth. You will develop multi-year plans, remove barriers to patient access, coordinate with reimbursement and market access teams, and guide senior account strategy to
Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com .
Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance's broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com .
The Business Development Director, Sales is a senior field leader who sets the account strategy and drives commercial growth across a large U.S. territory in support of Iovance Biotherapeutics' goals. Reporting to the Vice President, US Sales, this role leads the company's relationships with the most important oncology accounts, authorized treatment centers, health systems, and health care leaders in the assigned territory. The Director decides where to focus effort for the greatest impact, works to remove barriers to patient access and operational readiness for cell therapy delivery, and brings customer and market insights back to senior leadership to help guide national decisions.